The De La Salle Medical and Health Sciences Institute is a medical school and allied health institution in Dasmariñas, Cavite, Philippines. It was established in 1979 and is a constituent of De La Salle Philippines.

During the past decade, De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC)" #1 collaborator was "Dynavax Technologies Corporation" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC)" are "Hepatitis B" (2 trials), "HIV Infection" (1 trials), "HIV Infections" (1 trials) and "Tuberculosis, MDR" (1 trials). Many other conditions were trialed in "De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC)" in a lesser frequency.

Most popular intervention types in "De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC)" are "Drug" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Delamanid (DLM)" (1 trials), "ENGERIX-B" (1 trials), "HEPLISAV-B" (1 trials), "Isoniazid (INH)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC)". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".